Contact
searchSearch
HMP Global
Login

Posters

(#8) Project C.C.R.I.S.I.S.: Community-based Crisis Response Intervention Strategies for Interdisciplinary Standardization
Abstract: nurses can be influential leaders working to improve access to care for the over 3.5 million children and adolescents in the United States who need psychiatric care but struggle...
07/10/2025
(#9) Efficacy and Safety of AXS-05 in Alzheimer's Disease Agitation: A Phase 3 Randomized-Withdrawal Double-Blind Placebo-Controlled Study
Abstract: Approximately 70% of individuals with Alzheimerís disease (AD) experience agitation. Current pharmacologic therapies are limited and additional treatments are needed. AXS-05 (de...
07/10/2025
(#59) A Literature Review of SSRI-Induced Akathisia and its Potential Role in Suicidality
Abstract: Objectives: This review aims to provide an overview of SSRI-induced akathisia, examining its prevalence, underlying mechanisms, and potential role in increasing suicidality. Me...
07/10/2025
LAI360 Learning Lab: Raising the Bar on Schizophrenia Outcomes: Optimizing the Role of Long-Acting Injectable Antipsychotics
While antipsychotic treatment is essential to achieving and maintaining remission in schizophrenia, conventional antipsychotic treatments are associated with numerous shortcomings, includ...
07/10/2025
(#6) ADHD and Comorbid Diagnosis: Considerations of Prevalence In Clinical Settings Using Bayesian Statistics
Abstract: This presentation explores the rates of ADHD being diagnosed, suggesting potential underdiagnosis, particularly in patients presenting with anxiety and depression. These co-occu...
07/10/2025
Navigating the Spectrum of Bipolar Disorder: New Options with Novel Mechanisms of Action
Bipolar disorder (BD) is a serious mental illness and a notoriously challenging disease for healthcare professionals to accurately diagnose and manage. As a result, high rates of undertre...
07/10/2025
(#60) Clenched Secrets: The Hidden Side Effects of Psychiatric Meds
Abstract: Bruxism, a debilitating condition characterized by involuntary teeth grinding, has been increasingly linked to pharmacological treatments, though the underlying mechanisms remai...
07/10/2025
TD360 Learning Lab: Facing the Impact of Tardive Dyskinesia
Tardive dyskinesia (TD), which affects over 500,000 people in the United States (US), is an involuntary movement disorder associated with dopamine-receptor antagonistsñmost commonly antip...
07/10/2025
(#61) The Point of No Return? Cannabis Addiction and Lasting Psychosis
Abstract: This case examines a 23-year-old male whose cannabis addiction precipitated treatment-resistant psychosis. After one year of heavy use, he developed paranoid delusions (e.g., be...
07/10/2025
(#63) ìThe Pregnancy Test is Lying:" A Case Report on a Four-Year Battle of Undiagnosed Delusion of Pregnancy
Abstract: Both pseudocyesis and delusion of pregnancy are so rare that most information on them is found within case reports. Considering the similar presentation and risk factors of both...
07/10/2025

NEW FROM THE NP INSTITUTE ONLINE LEARNING HUB

andrew and julie
Rapid Refresh
Navigating Bipolar Disorder Treatment: Exploring the Role of Second-Generation Antipsychotics
04/11/2024

Featuring Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN

Featuring Andrew Penn, MS, PMHNP, and...
Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN, explore the nuanced role of second-generation antipsychotics in bipolar disorder treatment. They discuss the complexities of managing mania and depression phases and...
Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN, explore the nuanced role of second-generation antipsychotics in bipolar disorder treatment. They discuss the complexities of managing mania and depression phases and...
Andrew Penn, MS, PMHNP, and...
04/11/2024
Psych Congress NP Institute
Amber Hoberg
Rapid Refresh
Long-Acting Injectables for Adolescents With Schizophrenia and Schizoaffective Disorder
04/10/2024
Amber Hoberg, PMHNP-BC, navigates the complexities of adolescent psychosis treatment, exploring the potential benefits and considerations of LAIs for schizophrenia and schizoaffective disorder, while emphasizing evidence-based practice for...
Amber Hoberg, PMHNP-BC, navigates the complexities of adolescent psychosis treatment, exploring the potential benefits and considerations of LAIs for schizophrenia and schizoaffective disorder, while emphasizing evidence-based practice for...
Amber Hoberg, PMHNP-BC,...
04/10/2024
Psych Congress NP Institute
Hoberg and Matthews
Clinical Pearls
Tolerability Testing in Long-Acting Injectable Prescriptions
04/03/2024
Do clinicians need to test for tolerability before prescribing a long-acting injectable (LAI)? Desiree Matthews, PMHNP-BC, and Amber Hoberg, MSN, APRN, PMHNP-BC, offer their clinical insight.
Do clinicians need to test for tolerability before prescribing a long-acting injectable (LAI)? Desiree Matthews, PMHNP-BC, and Amber Hoberg, MSN, APRN, PMHNP-BC, offer their clinical insight.
Do clinicians need to test for...
04/03/2024
Psych Congress NP Institute

Sign Up

Psych Congress Network Newsletter

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2025 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use